Charles River Laboratories International (CRL) Non-Current Deferred Tax Liability (2010 - 2025)

Charles River Laboratories International's Non-Current Deferred Tax Liability history runs 14 years deep, the most recent figure standing at $95.2 million for Q4 2025.

• In Q4 2025, Non-Current Deferred Tax Liability fell 10.99% year-over-year to $95.2 million; the TTM figure through Dec 2025 stood at $95.2 million (down 10.99% YoY), while the FY2025 annual figure was $95.2 million, down 10.99% from the prior year.
• Non-Current Deferred Tax Liability was $95.2 million for Q4 2025 at Charles River Laboratories International, down from $123.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $420.6 million in Q4 2021 to a low of $95.2 million in Q4 2025.
• Historically, Non-Current Deferred Tax Liability has averaged $193.6 million across 5 years, with a median of $193.7 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Non-Current Deferred Tax Liability surged 30.12% in 2021, then plunged 48.74% in 2022.
• A 5-year view of Non-Current Deferred Tax Liability shows it stood at $420.6 million in 2021, then slumped by 48.74% to $215.6 million in 2022, then fell by 11.24% to $191.3 million in 2023, then sank by 44.1% to $107.0 million in 2024, then decreased by 10.99% to $95.2 million in 2025.
• The last three Non-Current Deferred Tax Liability figures came in at $95.2 million (Q4 2025), $123.0 million (Q3 2025), and $109.3 million (Q2 2025), per Business Quant data.